Severe optic neuropathy caused by dichloromethane inhalation. | Canada Hyperbarics Skip to main content
Clinical Study Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2008

Severe optic neuropathy caused by dichloromethane inhalation.

Kobayashi A, Ando A, Tagami N, Kitagawa M, Kawai E, Akioka M, et al. — Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of severe optic neuropathy in a 65-year-old man following dichloromethane inhalation.

What They Found

They found that the patient developed severe optic neuropathy, presenting with visual acuity of 0.3 in both eyes and critical flicker frequency values of 30 and 25 Hz. Goldmann perimetry showed concentric contractions of the visual field by 10 degrees in both eyes, and despite treatment, visual disturbance and optic nerve atrophy worsened.

Canadian Relevance

This study has no direct Canadian connection as it is a single case report from outside Canada.

Study Limitations

A key limitation of this study is that it is a single case report, which restricts the generalizability of its findings to a broader population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Ocular / Retinal
Source Pubmed
PubMed ID 19049266
Year Published 2008
Journal Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
MeSH Terms Aged; Humans; Inhalation Exposure; Male; Methylene Chloride; Optic Nerve Diseases

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology